Sage Therapeutics Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Operating Revenue	431.65	377.16	117.99	222.5	183.36	203.42
Other Revenue	-	-	-	-	-	0
Revenue	431.65	377.16	117.99	222.5	183.36	203.43
Revenue Growth (YoY)	40.73%	219.65%	-46.97%	21.34%	-9.87%	-
Cost of Revenue	375.53	331.3	100.88	191.53	167.88	190.81
Gross Profit	56.12	45.86	17.12	30.96	15.48	12.62
Selling, General & Admin	9.21	8.51	2.73	3.97	2.95	2.08
Other Operating Expenses	5.04	5.36	0.29	-0.26	3.29	2.26
Operating Expenses	15.99	16.16	5.47	7.02	10.21	7.1
Operating Income	40.13	29.7	11.65	23.95	5.27	5.52
Interest Expense	-11.59	-9.32	-5.69	-5.09	-6.36	-3.7
Interest & Investment Income	-	-	-	0.12	0.07	0.04
Other Non Operating Income (Expenses)	-1.46	-1.03	0.59	0.36	0.71	-0.47
Pretax Income	27.08	19.35	6.55	19.33	-0.31	1.39
Income Tax Expense	7.32	4.94	1.68	4.89	-0.19	0.61
Net Income	19.75	14.42	4.87	14.45	-0.12	0.77
Net Income to Common	19.75	14.42	4.87	14.45	-0.12	0.77
Net Income Growth	115.49%	196.31%	-66.31%	-	-	-
Shares Outstanding (Basic)	8	8	6	5	5	5
Shares Outstanding (Diluted)	8	8	6	5	5	5
Shares Change (YoY)	-18.37%	28.28%	12.80%	-	-	-
EPS (Basic)	2.56	1.86	0.81	2.70	-0.02	0.14
EPS (Diluted)	2.56	1.86	0.81	2.70	-0.02	0.14
EPS Growth	163.97%	130.99%	-70.14%	-	-	-
Free Cash Flow	-82.43	-105.34	-154.82	24.88	10.4	-2.1
Free Cash Flow Per Share	-10.67	-13.59	-25.62	4.64	1.94	-0.39
Gross Margin	13.00%	12.16%	14.51%	13.92%	8.44%	6.20%
Operating Margin	9.30%	7.88%	9.87%	10.76%	2.88%	2.71%
Profit Margin	4.58%	3.82%	4.12%	6.49%	-0.06%	0.38%
Free Cash Flow Margin	-19.10%	-27.93%	-131.21%	11.18%	5.67%	-1.03%
EBITDA	42.41	32	14.1	27.25	9.24	8.28
EBITDA Margin	9.83%	8.48%	11.95%	12.25%	5.04%	4.07%
D&A For EBITDA	2.28	2.29	2.45	3.3	3.97	2.76
EBIT	40.13	29.7	11.65	23.95	5.27	5.52
EBIT Margin	9.30%	7.88%	9.87%	10.76%	2.88%	2.71%
Effective Tax Rate	27.05%	25.50%	25.66%	25.29%	-	44.16%
Revenue as Reported	431.45	377.39	118.63	226.29	184.49	203.9
Advertising Expenses	-	-	-	-	0	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.